Pharma Mar Sau Stock Market Value

PHMMF Stock  USD 86.26  0.00  0.00%   
Pharma Mar's market value is the price at which a share of Pharma Mar trades on a public exchange. It measures the collective expectations of Pharma Mar SAU investors about its performance. Pharma Mar is trading at 86.26 as of the 26th of December 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 86.26.
With this module, you can estimate the performance of a buy and hold strategy of Pharma Mar SAU and determine expected loss or profit from investing in Pharma Mar over a given investment horizon. Check out Pharma Mar Correlation, Pharma Mar Volatility and Pharma Mar Alpha and Beta module to complement your research on Pharma Mar.
Symbol

Please note, there is a significant difference between Pharma Mar's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharma Mar is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharma Mar's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Pharma Mar 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharma Mar's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharma Mar.
0.00
11/26/2025
No Change 0.00  0.0 
In 31 days
12/26/2025
0.00
If you would invest  0.00  in Pharma Mar on November 26, 2025 and sell it all today you would earn a total of 0.00 from holding Pharma Mar SAU or generate 0.0% return on investment in Pharma Mar over 30 days. Pharma Mar is related to or competes with Neuren Pharmaceuticals, Genus Plc, PeptiDream, Oxford Nanopore, Mesoblast, CStone Pharmaceuticals, and Green Thumb. Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization o... More

Pharma Mar Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharma Mar's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharma Mar SAU upside and downside potential and time the market with a certain degree of confidence.

Pharma Mar Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharma Mar's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharma Mar's standard deviation. In reality, there are many statistical measures that can use Pharma Mar historical prices to predict the future Pharma Mar's volatility.
Hype
Prediction
LowEstimatedHigh
84.2886.2688.24
Details
Intrinsic
Valuation
LowRealHigh
77.6392.0694.05
Details
Naive
Forecast
LowNextHigh
84.2086.1888.16
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
78.9790.96102.95
Details

Pharma Mar SAU Backtested Returns

Pharma Mar SAU maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11 % return per unit of risk over the last 3 months. Pharma Mar SAU exposes seventeen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pharma Mar's Risk Adjusted Performance of (0.07), variance of 3.73, and Coefficient Of Variation of (950.12) to confirm the risk estimate we provide. The company holds a Beta of 0.4, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pharma Mar's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pharma Mar is expected to be smaller as well. At this point, Pharma Mar SAU has a negative expected return of -0.21%. Please make sure to check Pharma Mar's variance, as well as the relationship between the value at risk and day median price , to decide if Pharma Mar SAU performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  Huge  

Perfect predictability

Pharma Mar SAU has perfect predictability. Overlapping area represents the amount of predictability between Pharma Mar time series from 26th of November 2025 to 11th of December 2025 and 11th of December 2025 to 26th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharma Mar SAU price movement. The serial correlation of 9.223372036854776E16 indicates that 9.223372036854776E16% of current Pharma Mar price fluctuation can be explain by its past prices.
Correlation Coefficient92233.7 T
Spearman Rank Test0.1
Residual Average0.0
Price Variance0.0

Pharma Mar SAU lagged returns against current returns

Autocorrelation, which is Pharma Mar pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pharma Mar's pink sheet expected returns. We can calculate the autocorrelation of Pharma Mar returns to help us make a trade decision. For example, suppose you find that Pharma Mar has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Pharma Mar regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pharma Mar pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pharma Mar pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pharma Mar pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Pharma Mar Lagged Returns

When evaluating Pharma Mar's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pharma Mar pink sheet have on its future price. Pharma Mar autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pharma Mar autocorrelation shows the relationship between Pharma Mar pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Pharma Mar SAU.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Pharma Pink Sheet

Pharma Mar financial ratios help investors to determine whether Pharma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharma with respect to the benefits of owning Pharma Mar security.